Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️

前往频道在 Telegram

Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post

显示更多

印度22 863 教育10 751...

📈 Telegram 频道 Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ 的分析概览

频道 Vedemy (CSIR NET Life Science/GATE/DBT/ICMR/NEET) ️ (@smartlearningacademy) 英语语言赛道中的是活跃参与者。目前社区聚集了 18 613 名订阅者，在教育类别中位列第 10 751，并在印度地区排名第 22 863 位。

📊 受众指标与增长动态

自 невідомо 创建以来，项目保持高速增长，吸引了 18 613 名订阅者。

根据 03 七月, 2026 的最新数据，频道保持稳定运转。过去 30 天订阅人数变化为 255，过去 24 小时变化为 3，整体触达仍然可观。

认证状态： 未认证
互动率 (ER)： 平均受众互动率为 13.13%。内容发布后 24 小时内通常能获得 6.02% 的反应，占订阅者总量。
帖子覆盖： 每篇帖子平均可获得 2 443 次浏览，首日通常累积 1 121 次浏览。
互动与反馈： 受众积极参与，单帖平均反应数为 6。
主题关注点： 内容集中在 vedemy, nat, revision, calculation, rahe 等核心主题上。

📝 描述与内容策略

作者将该频道定位为表达主观观点的平台：
“Join this group if you are preparing for life science and biotechnology exams. No sharing of other coaching's copyrighted material. No spam No promotion No personal message to any member No irrelevant discussion No irrelevant post”

凭借高频更新（最新数据采集于 04 七月, 2026），频道始终保持新鲜度与高覆盖。分析显示受众积极互动，使其成为教育类别中的关键影响点。

18 613

订阅者

+324 小时

+567 天

+25530 天

2 443

帖子浏览量

~ 1 12124 小时

~ 1 49948 小时

13.13%

参与率

~ 3

每日帖子数

Ads index

beta

帖子存档

18 613

https://www.youtube.com/live/OsRTpC6nhnw?si=B-lyr53BR_b8cykH

18 613

🌐 RESEARCH UPDATE-1 🌐 AAV VECTORS TESTED IN PERFUSED HUMAN LIVERS The performance of AAV gene-therapy vectors is being explored in machine-perfused human livers. Interestingly, the presence of fatty liver disease influences the effectiveness of these vectors. This research could pave the way for more targeted and efficient gene therapies. Stay tuned for more updates on the latest breakthroughs in biotechnology! Source: Nature Biotechnology Powered by Vedemy 🔬💉 #GeneTherapy #AAVVectors #Biotechnology #ResearchUpdate #LiverDisease #FattyLiver #NatureBiotechnology #ScientificBreakthrough #HealthcareInnovation #Vedemy #ScienceNews #MedicalResearch #GeneticEngineering #BiotechNews #GeneEditing #BiologyLovers #MedicalInnovation

18 613

https://youtube.com/live/rj7INv-X1IQ?feature=share.

18 613

https://youtube.com/live/rj7INv-X1IQ?feature=share

18 613

📢 CSIR-UGC NET DEC 2024: Exam City Allotment Released! 📅 Exam Dates: 28th Feb – 2nd March 2025 📌 Check your allotted exam city now! 🔗 Download Slip: [https://csirnet.nta.ac.in](https://csirnet.nta.ac.in) ⚠️ Note: This is *NOT* the Admit Card. The actual Admit Card will be issued separately. For queries, contact NTA Helpdesk 📞 011-40759000 / 011-6922770 Stay updated with [www.nta.ac.in](http://www.nta.ac.in) & [csirnet.nta.ac.in](https://csirnet.nta.ac.in) #CSIRNET #ExamUpdate #NTA

18 613

🚂 All Aboard! 🚂 Get ready for a superfast biochemistry crash course! CSIR Recall Express 3.0 | Biochemistry | Unit 1 | Virendra Singh 🗓 Date: Today! ⏰ Time: LIVE on YouTube! 🚀 Buckle up for high-speed revision and Superfast Recalling techniques that'll turbocharge your CSIR Dec 2024 prep! 🔔 Don’t miss this! Join the Recall Express and let’s power through Unit 1 in record time! Click to board now! 🚉 🔗 https://www.youtube.com/live/FBrTMd6Zte8?si=cRclboB8pXd5YUiv See you on the tracks! ✨